News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Pittsburgh Life Sciences Greenhouse Acquires Additional Preferred Stock in Lipella Pharmaceuticals Inc.


7/2/2013 8:30:32 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PITTSBURGH--(BUSINESS WIRE)--The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, today announced that it has recently converted a prior convertible debt investment into Lipella Pharmaceuticals Inc. Series A Preferred Stock. Lipella develops new drugs for several urinary bladder diseases that affect millions of people worldwide.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES